From: Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairment
 | aMCI (N = 34) | naMCI (n = 15) | 95 % CI | P value |
---|---|---|---|---|
Female (%) | 12 (35 %) | 7 (47 %) | −0.41 to 0.19 | 0.53 |
Multi-domain N (%) | 13 (38 %) | 4 (27 %) | −0.16 to 0.39 | 0.43 |
Domains affected | Â | Â | Â | Â |
 Memory | 34 (100 %) | n/a | n/a | n/a |
 Executive | 11 (32 %) | 10 (67 %) | −0.63 to −0.06 | 0.03 |
 Language | 4 (12 %) | 5 (33 %) | −0.50 to 0.03 | 0.11 |
 Visuospatial | 2 (6 %) | 3 (20 %) | −0.42 to 0.06 | 0.16 |
 Attention | 1 (3 %) | 2 (13 %) | −0.36 to 0.07 | 0.22 |
Age at death, yrs | 88 ± 8 | 83 ± 7 | 0.4 to 9.8 | 0.03 |
Interval last neuro exam till death, months | 15 ± 15 | 11 ± 7.7 | −0.61 to 0.67 | 0.86 |
Education, yrs. | 15 ± 3 | 16 ± 2 | −3.3 to 0.0 | 0.05 |
APOE 4 carriers | 9 (26 %) | 6 (40 %) | −0.43 to 0.15 | 0.50 |
Last MMSE | 27 ± 2 | 27 ± 2 [n = 14] | −1.8 to 0.9 | 0.55 |
Interval last MMSE till death, months | 15 ± 15 | 10 ± 5 [n = 14] | −3.3 to 13.2 | 0.23 |
Last UPDRS | 20 ± 16 [n = 33] | 23 ± 17 | −13 to 8 | 0.63 |
Interval last UPDRS till death, months | 15 ± 15 | 17 ± 19 | −12 to 9 | 0.78 |